An overview of the Cirustrading automated systems available through the TradingMotion / iSystems platform. Live (real-account) results are shown separately from tracked / back-tested figures. Data as of 7 Nov 2026.
The strategies with the strongest tracked results this period. Tap any card for its full TradingMotion sheet.
All systems · November 2026
| Market | Strategy | Req. Capital | This Month | Result 2026 | Avg Month | Real (live) |
|---|---|---|---|---|---|---|
| EUROFX | CIRUS EURFX ST13 ROGY | 3.500 € | -326 €-9% | 12.512 €357% | 1.137 €32% | 6.816 €195% |
| EUROFX | RVST EUROFX 180 | 3.800 € | -321 €-8% | 6.254 €165% | 569 €15% | -10.611 €-279% |
| EUROFX | CIRUS EUROFX ST20 NANCA | 2.500 € | 181 €7% | 12.522 €501% | 1.138 €46% | 5.408 €216% |
| 10Y T-NOTE | CONES TNOTE SWISS 90 90 | 2.300 € | -60 €-3% | 1.504 €65% | 137 €6% | -1.704 €-74% |
| EUROFX | CIRUS EUROFX ST23RV NANVE | 2.500 € | -316 €-13% | 16.362 €654% | 1.487 €59% | — |
| EUROFX | CIRUS EUROFX ST24 ROJME | 3.500 € | -326 €-9% | 11.412 €326% | 1.037 €30% | — |
| EUROFX | CIRUS EUROFX ST27 SL | 2.500 € | 1.437 €57% | 8.461 €338% | 769 €31% | — |
| EUROFX | CIRUS EUROFX ST29 DISNEY | 3.500 € | -326 €-9% | 14.543 €416% | 1.322 €38% | — |
| GOLD | CIRUS ST5 GOLD PERSEO | 27.800 € | 19.806 €71% | 231.956 €834% | 21.087 €76% | 31.676 €114% |
| EUROFX | CIRUS EUROFX ST12 NUQLAR | 2.500 € | -326 €-13% | 10.492 €420% | 954 €38% | — |
| EUROFX | CIRUS EUROFX ST24RV SECHA | 2.500 € | -316 €-13% | 15.137 €605% | 1.376 €55% | — |
| EUROFX | CIRUS EUROFX ST24RV RECLA | 2.500 € | 196 €8% | 11.916 €477% | 1.083 €43% | — |
| EUROFX | CIRUS EUROFX ST29 ANNA | 3.500 € | -326 €-9% | 10.667 €305% | 970 €28% | — |
| EUROFX | CIRUS ST6 EUROFX 360 | 3.400 € | 181 €5% | 6.477 €190% | 589 €17% | — |
| EUROFX | CIRUS ST EUROFX ST25 SEPTOBER | 2.500 € | -326 €-13% | 11.438 €458% | 1.040 €42% | — |
| EUROFX | CIRUS EUROFX ST29 ELSA | 3.500 € | -326 €-9% | 13.497 €386% | 1.227 €35% | — |
| EUROFX | CIRUS EUROFX ST13 ASUS ALLY | 3.500 € | -326 €-9% | 9.070 €259% | 825 €24% | — |
This Month = November 2026 (in progress). Result 2026 = Jan–Nov P/L. Avg Month = Result 2026 ÷ 11. Real (live) = result since the strategy went live on a real account; “—” = no live track record yet. % = over Required Capital. Figures without a live track record are hypothetical / back-tested.
Not advice. This material is for informational purposes only. It is not investment advice, nor an offer, solicitation or recommendation to buy or sell any futures contract or other financial instrument, or to adopt any trading strategy. Cirustrading is not a registered investment adviser or commodity trading advisor.
Risk of loss. Trading futures involves substantial risk of loss and is not suitable for all investors; you may lose more than your initial investment. Past performance, whether actual or hypothetical / back-tested, is not necessarily indicative of future results.
Hypothetical performance (CFTC Rule 4.41 / NFA): HYPOTHETICAL PERFORMANCE RESULTS HAVE MANY INHERENT LIMITATIONS. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN. IN FACT, THERE ARE FREQUENTLY SHARP DIFFERENCES BETWEEN HYPOTHETICAL PERFORMANCE RESULTS AND THE ACTUAL RESULTS SUBSEQUENTLY ACHIEVED BY ANY PARTICULAR TRADING PROGRAM. ONE OF THE LIMITATIONS OF HYPOTHETICAL PERFORMANCE RESULTS IS THAT THEY ARE GENERALLY PREPARED WITH THE BENEFIT OF HINDSIGHT. IN ADDITION, HYPOTHETICAL TRADING DOES NOT INVOLVE FINANCIAL RISK, AND NO HYPOTHETICAL TRADING RECORD CAN COMPLETELY ACCOUNT FOR THE IMPACT OF FINANCIAL RISK IN ACTUAL TRADING.